Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  topotecan hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 338 for your search:
Start Over
Phase III Randomized Study of Topotecan vs Observation Following CDDP/VP-16 for Extensive Stage Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E7593, E7593
Phase III Randomized Study of TOPO vs CAV (CTX/DOX/VCR) as Second-Line Therapy for Recurrent Small Cell Lung Cancer (Summary Last Modified 06/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SB-104864/090, NCI-V95-0673
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067138, GOG-0179, ECOG-G0179, NCT00003945
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: D9803, NCI-2012-02302, IRS-D9803, COG-D9803, POG-D9803, CDR0000067157, CCG-D9803, U10CA098543, NCT00003958
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: A3973, COG-A3973, CCG-A3973, POG-A3973, CCG-39703, FHCRC-1631.00, CDR0000067429, NCT00004188
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067994, AGOSG-OVAR-7, NCI-V00-1602, NCT00006454
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: GOG-0182, NCI-2012-02376, SWOG-G0182, CDR0000068467, ISRCTN41636183, MRC-ICON5, ECOG-G0182, U10CA027469, NCT00011986
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0204, NCT00064077
Phase III Randomized Study of TLK286 Versus Doxorubicin HCl Liposome or Topotecan as Third-Line Therapy in Patients With Platinum-Refractory or -Resistant Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03087, TLK-286.3017, NCT00078884
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: RET5, P01CA023099, NCT00186888
Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 3104000, NCT00437307
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0531, COG-ANBL0531, CDR0000554708, NCI-2009-00400, NCT00499616
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KTN32313R, NCT00477282
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMR PH GL 2007 CL001, NCT00547651
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0532, NCI-2009-01065, CDR0000576571, COG-ANBL0532, U10CA098543, NCT00567567
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01084, CDR0000628746, GOG-0240, U10CA180868, U10CA027469, NCT00803062
Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: OV16, CAN-NCIC-OV16, EORTC-55012, GEICO-0101, CDR0000069129, NCT00028743
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO22224, 2009-011400-33, NCT00976911
Start Over